We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Futu Holdings
FUTU
|
+$32.5M |
| 2 |
Applied Materials
AMAT
|
+$26.5M |
| 3 |
Apple
AAPL
|
+$13.7M |
| 4 |
Microsoft
MSFT
|
+$11.9M |
| 5 |
NVIDIA
NVDA
|
+$9.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$28.3M |
| 2 |
KE Holdings
BEKE
|
+$13.2M |
| 3 |
TSMC
TSM
|
+$13.2M |
| 4 |
ASE Group
ASX
|
+$7.59M |
| 5 |
iQIYI
IQ
|
+$6.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
MacroGenics
MGNX
$211M
| – | – |
-16,667
| Closed | -$245K | – |
|
352
Mirum Pharmaceuticals
MIRM
$5.19B
| – | – |
-12,583
| Closed | -$316K | – |
|
353
Molina Healthcare
MOH
$10.9B
| – | – |
-546
| Closed | -$224K | – |
|
354
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-696
| Closed | -$78K | – |
|
355
Myriad Genetics
MYGN
$396M
| – | – |
-11,776
| Closed | -$251K | – |
|
356
Olema Pharmaceuticals
OLMA
$572M
| – | – |
-13,927
| Closed | -$158K | – |
|
357
Pultegroup
PHM
$21.6B
| – | – |
-3,104
| Closed | -$374K | – |
|
358
Prothena Corp
PRTA
$425M
| – | – |
-14,340
| Closed | -$355K | – |
|
359
PTC Therapeutics
PTCT
$4.98B
| – | – |
-13,908
| Closed | -$405K | – |
|
360
Protagonist Therapeutics
PTGX
$8.39B
| – | – |
-11,304
| Closed | -$327K | – |
|
361
PVH
PVH
$3.98B
| – | – |
-2,888
| Closed | -$406K | – |
|
362
Invesco QQQ Trust
QQQ
$480B
| – | – |
-3,781
| Closed | -$1.68M | – |
|
363
Ferrari
RACE
$69.8B
| – | – |
-1,862
| Closed | -$812K | – |
|
364
Rocket Pharmaceuticals
RCKT
$250M
| – | – |
-15,549
| Closed | -$419K | – |
|
365
Arcus Biosciences
RCUS
$2.78B
| – | – |
-16,052
| Closed | -$303K | – |
|
366
Replimune Group
REPL
$1.04B
| – | – |
-30,342
| Closed | -$248K | – |
|
367
ResMed
RMD
$33.7B
| – | – |
-1,177
| Closed | -$233K | – |
|
368
Rhythm Pharmaceuticals
RYTM
$6B
| – | – |
-10,333
| Closed | -$448K | – |
|
369
DELISTED
Sage Therapeutics
SAGE
| – | – |
-18,544
| Closed | -$348K | – |
|
370
SiriusXM
SIRI
$9.15B
| – | – |
-3,214
| Closed | -$125K | – |
|
371
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-5,016
| Closed | -$215K | – |
|
372
Scholar Rock
SRRK
$4.9B
| – | – |
-16,339
| Closed | -$290K | – |
|
373
Scorpio Tankers
STNG
$4.13B
| – | – |
-3,591
| Closed | -$257K | – |
|
374
Tango Therapeutics
TNGX
$3.75B
| – | – |
-10,398
| Closed | -$82.6K | – |
|
375
Trex
TREX
$4.7B
| – | – |
-4,763
| Closed | -$475K | – |
|
Similar funds
E Fund Management's Q2 2024 Portfolio in Review
As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.
- E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
- E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
- E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
- E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
- E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
- E Fund Management opened 24 new positions and closed 74 in Q2 2024.
- E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.
Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.